Keystone Heart Acquires 510 Kardiac Devices, Inc.

Abbott Acquires Cardiovascular Systems, Inc.

February 8, 2023

Medical Devices

Abbott has agreed to acquire Cardiovascular Systems, Inc. (CSI) for $20.00 per share, representing an expected equity value of approximately $890 million. The acquisition adds CSI's orbital atherectomy system and early-stage vascular intervention pipeline to Abbott's vascular device portfolio to expand its capabilities in treating peripheral and coronary artery disease.

QIA Leads $250M Financing in Kardium to Support Commercial Launch

July 2, 2025

Medical Devices

Kardium Inc., a Vancouver/Burnaby-based medical device company developing the Globe Pulsed Field System for atrial fibrillation, raised USD 250 million in a financing round led by the Qatar Investment Authority (QIA). The growth-capital raise, which included new investors Janus Henderson Investors, MM Capital, Piper Heartland Healthcare Capital, Eventide Asset Management, Eckuity Capital and participation from existing investors such as T. Rowe Price and Durable Capital, will fund regulatory approvals, the commercial launch and expansion of manufacturing capabilities.

Philips Acquires Intact Vascular

August 27, 2020

Medical Devices

Royal Philips has signed an agreement to acquire Intact Vascular, a U.S.-based developer of the Tack Endovascular System, to expand Philips' image-guided therapy devices portfolio for peripheral artery disease. The deal includes USD 275 million upfront in cash plus deferred payments (up to ~USD 360 million total) and is expected to close in the third quarter of 2020, after which Intact Vascular will join Philips' Image-Guided Therapy business.

Cirtec Medical Acquires Cardea Catheter Innovations

July 26, 2021

Medical Devices

Cirtec Medical has acquired Cardea Catheter Innovations, a San Jose-based manufacturer of minimally invasive catheter devices and complex delivery systems. Cardea will integrate into Cirtec's NovelCath brand to expand the company's interventional capabilities across structural heart, electrophysiology, and neurovascular markets and will relocate into Cirtec's new San Jose Center of Excellence.

Picard Medical Acquires SynCardia Systems

September 30, 2021

Medical Devices

Picard Medical, a portfolio company of Hunniwell Lake Ventures, has acquired SynCardia Systems, the global leader in total artificial heart (TAH) technology. The deal brings SynCardia into Picard’s medical-device platform to accelerate product improvements, manufacturing capabilities, clinical support and pursuit of expanded regulatory approvals.

Modular Devices Acquires Cardiac Services Mobile

June 5, 2022

Healthcare Services

Modular Devices Acquisition, LLC has acquired Cardiac Services Mobile, Inc., a Nashville-based provider of mobile cardiac catheterization and peripheral vascular labs, expanding Modular Devices' interim lab capacity by about 33%. The deal, executed by Modular Devices (a portfolio company of O2 Investment Partners), strengthens the combined company's position as the largest provider of temporary mobile cath, EP and CT labs in the U.S. and supports planned upgrades and geographic/service expansion.